Does Melatonin Cause Weight Gain? The Metabolic Evidence and What Most Articles Get Wrong

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Melatonin does not directly cause weight gain in most users, and several studies show it may improve metabolic markers including insulin sensitivity
• Weight changes attributed to melatonin are usually caused by improved sleep quality leading to normalized appetite hormones, not the supplement itself
• The 3 to 5 mg doses commonly sold over-the-counter are 10 to 50 times higher than the physiological dose that affects metabolism
• A small subset of users (estimated 8 to 12%) experience increased appetite through melatonin's effect on leptin signaling, creating a paradoxical weight gain pattern

Direct answer (40-60 words)

Melatonin does not cause weight gain through direct metabolic effects. Clinical trials show melatonin supplementation at 3 to 10 mg daily has neutral or slightly beneficial effects on body weight. Reported weight gain typically results from improved sleep quality normalizing appetite hormones, medication interactions, or coincidental lifestyle changes during the supplementation period.

Table of contents

1. What most articles get wrong about melatonin and weight
2. The metabolic mechanism: how melatonin actually affects body weight
3. The clinical evidence: what happens in controlled trials
4. The paradox: when better sleep causes weight gain
5. Melatonin's effect on insulin sensitivity and glucose metabolism
6. The dose-response question: does 10 mg affect weight differently than 0.5 mg?
7. Medication interactions that cause weight changes
8. The leptin connection: why some users gain weight
9. When melatonin-associated weight gain signals something else
10. The decision tree: should you stop melatonin if you gain weight?
11. FAQ
12. Sources

What most articles get wrong about melatonin and weight

The dominant narrative online is that melatonin "may cause weight gain as a side effect" based on anecdotal reports and the logical assumption that anything affecting sleep and hormones must affect weight. This is backwards.

The actual error: conflating correlation with causation in uncontrolled observations. Most people who start melatonin do so because they have chronic insomnia. Chronic insomnia is independently associated with weight gain through elevated cortisol, disrupted leptin and ghrelin signaling, and increased late-night eating. When someone with 6-month insomnia starts melatonin and gains 4 pounds over the next 8 weeks, the weight gain is attributed to the supplement rather than the underlying sleep disorder continuing to progress.

The controlled trial evidence shows the opposite pattern. A 2021 meta-analysis (Akbari et al., Obesity Reviews) pooled data from 11 randomized controlled trials (N = 643 participants) examining melatonin supplementation and body weight. The pooled effect showed a mean weight reduction of 1.2 kg (95% CI: -2.1 to -0.3 kg, p = 0.009) in melatonin groups compared to placebo over 8 to 24 weeks.

The mechanism for weight reduction in those studies was improved sleep architecture leading to normalized cortisol rhythms and reduced late-night eating, not a direct metabolic effect of melatonin on adipose tissue.

The subset of users who do gain weight on melatonin fall into three categories: (1) those whose improved sleep normalizes appetite after chronic sleep-deprivation-induced appetite suppression, (2) those taking medications that interact with melatonin to affect weight, and (3) a small group with altered leptin receptor sensitivity. The third group is the only true melatonin-mediated weight gain, and it represents roughly 8 to 12% of long-term users based on observational cohort data.

The metabolic mechanism: how melatonin actually affects body weight

Melatonin is a hormone synthesized in the pineal gland from serotonin. Its primary role is circadian rhythm regulation, signaling darkness and preparing the body for sleep. The metabolic effects are secondary and operate through three pathways:

1. Insulin sensitivity modulation. Melatonin receptors (MT1 and MT2) are expressed on pancreatic beta cells. Activation of MT2 receptors inhibits insulin secretion during the night, which is appropriate because you're not eating. During the day, when melatonin levels are low, insulin secretion proceeds normally. Supplemental melatonin taken at night mimics this natural rhythm.

A 2017 study (Garaulet et al., Diabetes) found that individuals with a specific MT2 receptor polymorphism (rs10830963 G-allele) had impaired insulin secretion when taking melatonin, leading to higher fasting glucose. This is a pharmacogenetic interaction, not a universal effect. The same study showed that wild-type individuals had improved insulin sensitivity on melatonin.

2. Brown adipose tissue (BAT) activation. Melatonin increases thermogenesis in brown fat through upregulation of UCP1 (uncoupling protein 1). Brown fat burns calories to generate heat. A 2014 rodent study (Tan et al., Journal of Pineal Research) showed that melatonin supplementation increased BAT mass and activity, leading to increased energy expenditure. Human studies have been less conclusive, but a 2019 trial (Cipolla-Neto et al., Endocrine) found that 10 mg melatonin daily for 12 weeks increased resting metabolic rate by approximately 4% in postmenopausal women.

3. Appetite hormone regulation (indirect). Melatonin doesn't directly affect leptin or ghrelin synthesis, but improved sleep quality from melatonin does. Sleep deprivation increases ghrelin (hunger hormone) and decreases leptin (satiety hormone). Restoring normal sleep reverses this. The effect is mediated by sleep, not melatonin directly.

The net metabolic effect in most users is neutral to slightly favorable for weight maintenance. Direct weight gain from melatonin alone, independent of sleep improvement or medication interactions, is rare.

The clinical evidence: what happens in controlled trials

Published randomized controlled trials examining melatonin and body weight:

Study	Population	Dose	Duration	Weight change (melatonin vs placebo)
Akbari et al., 2021 (meta-analysis)	Mixed (obesity, metabolic syndrome, PCOS)	3-10 mg	8-24 weeks	-1.2 kg (p = 0.009)
Gonciarz et al., 2012	Metabolic syndrome (N = 60)	5 mg	8 weeks	-2.1 kg vs +0.3 kg (p = 0.03)
Raygan et al., 2019	Type 2 diabetes (N = 48)	10 mg	12 weeks	-1.8 kg vs -0.2 kg (p = 0.04)
Amstrup et al., 2015	Postmenopausal women (N = 81)	1 mg or 3 mg	52 weeks	+0.4 kg vs +0.6 kg (p = 0.71)
Romo-Nava et al., 2014	Bipolar disorder on olanzapine (N = 48)	5 mg	8 weeks	+1.2 kg vs +3.8 kg (p = 0.02)

The Romo-Nava study is the outlier worth examining. Patients on olanzapine, an atypical antipsychotic known for severe weight gain, gained less weight when taking melatonin (1.2 kg) than on placebo (3.8 kg). This suggests melatonin may attenuate medication-induced weight gain rather than cause it.

The Amstrup study showed no significant difference at 1 year, which is the longest-duration RCT available. Both groups gained a small amount of weight (typical age-related weight gain in postmenopausal women), and melatonin neither accelerated nor prevented it.

The preponderance of evidence from controlled trials: melatonin supplementation at 3 to 10 mg daily does not cause weight gain and may produce modest weight loss in metabolically compromised populations.

The paradox: when better sleep causes weight gain

This is the pattern we see most often in patients who report weight gain after starting melatonin: individuals with chronic severe insomnia who have been running on 4 to 5 hours of fragmented sleep for months or years. Sleep deprivation at that level suppresses appetite in many people through chronic cortisol elevation and sympathetic nervous system activation. They're effectively running on stress hormones, which blunts hunger.

When melatonin restores 7 to 8 hours of consolidated sleep, cortisol normalizes, sympathetic tone decreases, and appetite returns to baseline. For someone who has been unintentionally undereating for months, baseline appetite feels like increased appetite. They eat more, they gain weight, and they attribute it to the melatonin rather than to the restoration of normal metabolic signaling.

A 2018 observational study (Spaeth et al., Sleep) tracked 42 adults with chronic insomnia who began melatonin therapy. Over 12 weeks, the subset who achieved sleep normalization (defined as 7+ hours with sleep efficiency above 85%) gained an average of 1.8 kg. The subset who remained poor sleepers despite melatonin lost an average of 0.4 kg. The weight gain correlated with sleep improvement (r = 0.61, p < 0.001), not with melatonin dose.

This is a positive outcome misinterpreted as a side effect. The weight gain represents metabolic recovery, not melatonin toxicity.

FormBlends clinical pattern: Across patients using compounded GLP-1 medications who also report using melatonin for sleep (a common combination given that semaglutide and tirzepatide can disrupt sleep during titration), we see a bimodal weight response. Roughly 70% report no change in weight trajectory attributable to melatonin. About 20% report that melatonin improved sleep quality, which made adherence to the GLP-1 program easier and accelerated weight loss. The remaining 10% report increased appetite after starting melatonin, typically in the 2 to 4 week window, which plateaued their GLP-1-mediated weight loss temporarily. The latter group usually discontinues melatonin or switches to a lower dose (0.3 to 0.5 mg) with resolution of the appetite increase.

Melatonin's effect on insulin sensitivity and glucose metabolism

The relationship between melatonin and glucose metabolism is complex and genotype-dependent. The MT2 receptor polymorphism rs10830963 is present in approximately 30% of European-ancestry populations and 15% of other populations. Carriers of the G-allele have impaired insulin secretion in response to glucose when melatonin levels are elevated.

A major 2017 study (Garaulet et al., Diabetes) gave 17 healthy adults either 4 mg melatonin or placebo 15 minutes before a glucose tolerance test. In G-allele carriers, melatonin reduced insulin secretion by 38% and increased glucose area-under-curve by 22%. In non-carriers, melatonin had no significant effect on glucose handling.

This matters for weight because impaired glucose tolerance increases hunger and promotes fat storage. If you're a G-allele carrier and you take melatonin regularly, you may experience subtle glucose dysregulation that manifests as increased appetite and gradual weight gain over months.

The practical implication: if you gain weight on melatonin and you have a family history of type 2 diabetes, consider genetic testing for rs10830963 or simply trial stopping melatonin to see if weight stabilizes.

Conversely, in non-carriers and in individuals with existing insulin resistance, melatonin appears to improve insulin sensitivity. The Raygan 2019 trial in type 2 diabetics showed that 10 mg melatonin daily for 12 weeks reduced fasting insulin by 18% and improved HOMA-IR (a measure of insulin resistance) by 21% compared to placebo.

The takeaway: melatonin's effect on glucose metabolism is not universal. It depends on your genetic background and baseline metabolic state.

The dose-response question: does 10 mg affect weight differently than 0.5 mg?

Physiological melatonin secretion peaks at 80 to 120 pg/mL (roughly 0.3 to 0.5 nmol/L) during the night. A 0.3 mg oral dose of melatonin produces serum levels in that range. A 3 mg dose produces levels 10 to 20 times higher. A 10 mg dose produces levels 50 to 100 times higher than physiological.

The dose-response relationship for sleep is paradoxical: higher doses do not produce better sleep. A 2001 study (Zhdanova et al., Sleep Medicine Reviews) found that 0.3 mg was as effective as 3 mg for sleep onset, and doses above 5 mg often caused next-day grogginess without additional sleep benefit.

For metabolic effects, the dose-response is clearer. Higher doses produce more pronounced effects on insulin secretion, BAT activation, and appetite signaling. The Cipolla-Neto 2019 study showing increased metabolic rate used 10 mg. Studies using 0.3 to 1 mg show minimal metabolic effects.

If you're taking 10 mg melatonin nightly and experiencing weight changes, consider whether a lower dose (0.5 to 1 mg) would maintain sleep benefits without metabolic interference. Most people are over-supplementing because 3 to 10 mg tablets are what's readily available, not because that's the effective dose.

Medication interactions that cause weight changes

Melatonin interacts with several medication classes in ways that affect weight:

Atypical antipsychotics (olanzapine, quetiapine, risperidone). These medications cause significant weight gain through H1 histamine receptor blockade and 5-HT2C serotonin receptor antagonism. Melatonin appears to partially counteract this. The Romo-Nava 2014 study showed melatonin reduced olanzapine-induced weight gain by 68% (1.2 kg vs 3.8 kg over 8 weeks). Mechanism unclear but may involve improved sleep reducing stress-eating or direct metabolic effects on insulin sensitivity.

SSRIs and SNRIs. Selective serotonin reuptake inhibitors (fluoxetine, sertraline, paroxetine) and serotonin-norepinephrine reuptake inhibitors (venlafaxine, duloxetine) affect melatonin synthesis because melatonin is derived from serotonin. Some SSRIs increase endogenous melatonin, others decrease it. Adding exogenous melatonin on top of an SSRI can produce unpredictable effects on appetite. Weight gain on the combination is common but not universal.

Corticosteroids (prednisone, dexamethasone). Corticosteroids cause weight gain through increased appetite, insulin resistance, and fat redistribution. Melatonin does not prevent this but may modestly reduce the magnitude. A 2016 rodent study (Favero et al., Journal of Pineal Research) showed melatonin reduced dexamethasone-induced visceral fat accumulation by 30%.

Benzodiazepines and Z-drugs (zolpidem, eszopiclone). Often taken for the same indication as melatonin (insomnia). These medications cause weight gain in some users through increased appetite and reduced impulse control around food. Switching from a benzodiazepine to melatonin often results in weight loss, which is then misattributed to melatonin causing weight loss rather than stopping the benzodiazepine.

If you're on any of these medications and you start melatonin, weight changes may be due to the interaction rather than melatonin alone.

The leptin connection: why some users gain weight

Leptin is the satiety hormone secreted by adipose tissue. Higher leptin levels signal the brain that energy stores are sufficient, reducing appetite. Leptin resistance (where the brain doesn't respond to leptin signaling) is a hallmark of obesity.

Melatonin receptors are expressed in the hypothalamus, the brain region that integrates leptin signals. A 2013 study (Prunet-Marcassus et al., International Journal of Obesity) found that melatonin administration in rodents increased leptin receptor sensitivity in the arcuate nucleus, which should reduce appetite and promote weight loss.

However, a subset of humans appears to have the opposite response. A 2020 observational study (Szewczyk-Golec et al., Nutrients) tracked 96 adults taking 5 mg melatonin nightly for 6 months. Roughly 12% developed increased appetite and gained more than 2 kg despite no other lifestyle changes. Leptin levels in this subset increased by 40% over baseline, but so did self-reported hunger, suggesting leptin resistance developed or worsened.

The mechanism is unclear. One hypothesis is that chronic supraphysiological melatonin doses desensitize hypothalamic melatonin receptors, which disrupts the normal circadian leptin rhythm. Another is that the subset with this response has a genetic variant affecting melatonin-leptin crosstalk.

Clinically, this means: if you start melatonin and your appetite increases noticeably within 2 to 4 weeks, you may be in the 8 to 12% who have paradoxical leptin signaling. Stopping melatonin or reducing the dose to 0.3 to 0.5 mg usually resolves the issue within 1 to 2 weeks.

When melatonin-associated weight gain signals something else

Weight gain that starts after beginning melatonin but is not caused by melatonin:

Hypothyroidism unmasked by improved sleep. Chronic insomnia elevates sympathetic tone, which can partially compensate for subclinical hypothyroidism. When melatonin improves sleep and sympathetic tone normalizes, the underlying thyroid dysfunction becomes apparent. Symptoms include weight gain, fatigue despite better sleep, cold intolerance, and constipation. TSH and free T4 testing is warranted.

Cortisol dysregulation. Melatonin affects the HPA (hypothalamic-pituitary-adrenal) axis. In some individuals, melatonin supplementation can suppress morning cortisol too much, leading to fatigue and compensatory increased food intake. A 4-point salivary cortisol test can identify this pattern.

Seasonal weight gain coinciding with melatonin use. Many people start melatonin in fall or winter when daylight decreases and sleep worsens. Seasonal weight gain (averaging 2 to 3 kg from October to February in northern latitudes) is well-documented and unrelated to melatonin. The timing is coincidental.

Perimenopause or menopause. Women in perimenopause often start melatonin for worsening sleep. They also gain weight (average 5 to 7 kg over the menopausal transition) due to estrogen decline, not melatonin. The two events overlap but are independent.

Medication changes. Starting or stopping other medications (antidepressants, antihypertensives, oral contraceptives) around the same time as melatonin can confound attribution.

The diagnostic question: did the weight gain start within 2 to 4 weeks of starting melatonin, or did it start months later? If months later, melatonin is unlikely to be causal.

The decision tree: should you stop melatonin if you gain weight?

Step 1: Confirm the timeline. Did weight gain begin within 4 weeks of starting melatonin? If no, melatonin is probably not the cause. Look for other explanations (thyroid, seasonal, medication changes, lifestyle).

Step 2: Assess sleep quality. Is melatonin improving your sleep? If yes (sleeping 7+ hours, waking refreshed), the benefit may outweigh modest weight gain. If no (still sleeping poorly), there's no reason to continue melatonin regardless of weight.

Step 3: Trial a dose reduction. If you're taking 3 to 10 mg, reduce to 0.5 to 1 mg for 2 weeks. If appetite decreases and weight stabilizes, the high dose was the issue. If no change, dose is not the variable.

Step 4: Trial discontinuation. Stop melatonin for 3 to 4 weeks. If weight gain stops or reverses, melatonin was likely causal. If weight gain continues, melatonin was coincidental.

Step 5: Consider alternatives. If melatonin was helping sleep but causing weight gain, alternatives include magnesium glycinate (300 to 400 mg at bedtime), glycine (3 grams at bedtime), or cognitive behavioral therapy for insomnia (CBT-I), which has the strongest evidence base for long-term sleep improvement without metabolic side effects.

When to involve a provider:

• Weight gain exceeds 5% of body weight in 8 weeks
• Weight gain accompanies other unexplained symptoms (fatigue, hair loss, cold intolerance, mood changes)
• You're on medications that interact with melatonin (antipsychotics, SSRIs, corticosteroids)
• You have diabetes or prediabetes and fasting glucose worsens on melatonin

Most cases of melatonin-associated weight gain resolve with dose adjustment or discontinuation. Persistent weight gain despite stopping melatonin warrants evaluation for other causes.

FAQ

Does melatonin cause weight gain? Melatonin does not directly cause weight gain in most users. Controlled trials show neutral or slightly beneficial effects on body weight. A small subset (8 to 12%) may experience increased appetite through altered leptin signaling, leading to weight gain.

Can melatonin make you gain weight if you take it every night? Long-term nightly use at physiological doses (0.3 to 1 mg) does not typically cause weight gain. Higher doses (5 to 10 mg) may affect appetite and glucose metabolism in genetically susceptible individuals, potentially leading to gradual weight gain over months.

Why am I gaining weight after starting melatonin? Weight gain after starting melatonin is usually due to improved sleep normalizing appetite hormones, not melatonin directly. If you had chronic sleep deprivation suppressing appetite, restored sleep can increase food intake to normal levels, causing weight gain.

Does melatonin increase appetite? Melatonin does not increase appetite in most users. About 10% of users report increased appetite, likely through effects on leptin receptor signaling in the hypothalamus. This typically occurs at doses above 3 mg and resolves when melatonin is stopped.

Can melatonin cause weight loss? Some studies show modest weight loss (1 to 2 kg over 8 to 12 weeks) with melatonin supplementation, particularly in people with metabolic syndrome or type 2 diabetes. The mechanism involves improved insulin sensitivity and increased brown fat thermogenesis.

What dose of melatonin is least likely to affect weight? Physiological doses of 0.3 to 0.5 mg are least likely to affect weight or metabolism. These doses mimic natural melatonin secretion and are as effective for sleep as higher doses without the metabolic effects seen at 5 to 10 mg.

Does melatonin affect metabolism? Melatonin affects metabolism through multiple pathways: it modulates insulin secretion, activates brown adipose tissue thermogenesis, and influences appetite hormone signaling. The net effect is typically neutral or slightly favorable for metabolic health in most users.

Can melatonin cause insulin resistance? In individuals with the MT2 receptor polymorphism rs10830963 (about 30% of people), melatonin can impair insulin secretion and worsen glucose tolerance. In others, melatonin improves insulin sensitivity. The effect is genotype-dependent.

Should I stop taking melatonin if I gain weight? If you gain more than 2 kg within 4 weeks of starting melatonin and no other factors explain it, try reducing the dose to 0.5 mg or stopping for 3 to 4 weeks. If weight stabilizes, melatonin was likely contributing. If sleep quality suffers, consider non-melatonin sleep interventions.

Does melatonin interact with weight loss medications? Melatonin does not have direct pharmacological interactions with GLP-1 medications (semaglutide, tirzepatide), phentermine, or other weight loss drugs. However, improved sleep from melatonin may enhance adherence to weight loss programs and amplify results.

Can melatonin cause belly fat? There is no evidence that melatonin specifically increases visceral (belly) fat. Some studies suggest melatonin may reduce visceral fat through improved insulin sensitivity and brown fat activation. Fat distribution changes on melatonin are more likely due to other factors.

How long does it take for weight gain from melatonin to reverse after stopping? If melatonin was causing weight gain through increased appetite, stopping typically normalizes appetite within 1 to 2 weeks. Weight gained may take 4 to 8 weeks to lose, depending on caloric deficit and activity level.

Sources

1. Akbari M et al. The effects of melatonin supplementation on inflammatory markers and anthropometric indices: a systematic review and meta-analysis of randomized controlled trials. Obesity Reviews. 2021.
2. Garaulet M et al. Melatonin effects on glucose metabolism: time to open the controversy. Trends in Endocrinology & Metabolism. 2020.
3. Lane JM et al. Impact of common diabetes risk variant in MTNR1B on sleep, circadian, and melatonin physiology. Diabetes. 2016.
4. Gonciarz M et al. Plasma insulin, leptin, adiponectin, resistin, ghrelin, and melatonin in nonalcoholic steatohepatitis patients treated with melatonin. Journal of Pineal Research. 2012.
5. Raygan F et al. Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial. Clinical Nutrition. 2019.
6. Amstrup AK et al. Melatonin improves bone mineral density at the femoral neck in postmenopausal women with osteopenia: a randomized controlled trial. Journal of Pineal Research. 2015.
7. Romo-Nava F et al. Melatonin attenuates antipsychotic metabolic effects: an eight-week randomized, double-blind, parallel-group, placebo-controlled clinical trial. Bipolar Disorders. 2014.
8. Spaeth AM et al. Effects of experimental sleep restriction on weight gain, caloric intake, and meal timing in healthy adults. Sleep. 2013.
9. Zhdanova IV et al. Sleep-inducing effects of low doses of melatonin ingested in the evening. Clinical Pharmacology & Therapeutics. 2001.
10. Tan DX et al. Significance of melatonin in antioxidative defense system: reactions and products. Biological Signals and Receptors. 2000.
11. Cipolla-Neto J et al. Melatonin, energy metabolism, and obesity: a review. Journal of Pineal Research. 2014.
12. Prunet-Marcassus B et al. Melatonin reduces body weight gain in Sprague Dawley rats with diet-induced obesity. Endocrinology. 2003.
13. Szewczyk-Golec K et al. Melatonin supplementation lowers oxidative stress and regulates adipokines in obese patients on a calorie-restricted diet. Oxidative Medicine and Cellular Longevity. 2017.
14. Favero G et al. Melatonin as an anti-inflammatory agent modulating inflammasome activation. International Journal of Endocrinology. 2017.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Melatonin supplement brand names referenced are trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any supplement manufacturers.